Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Is drug pricing a problem?
Is drug pricing a problem?
by liane-varnes
Philip J. Schneider MS, FASHP, FASPEN, FFIP. Prof...
China Healthcare Industry and Market
China Healthcare Industry and Market
by avery223
Industry Introduction. Challenges & Opportunit...
The pharmaceutical industry
The pharmaceutical industry
by pasty-toler
March 27th 2014, University of Zurich . Fabienne ...
The pharmaceutical industry
The pharmaceutical industry
by alida-meadow
March 27th 2014, University of Zurich . Fabienne ...
OVERVIEW OF INDIAN PAHARMACEUTICAL INDUSTRY (IPI) AND AN INTRODUCTION OF ITS EVOLUATION
OVERVIEW OF INDIAN PAHARMACEUTICAL INDUSTRY (IPI) AND AN INTRODUCTION OF ITS EVOLUATION
by min-jolicoeur
. . IPI is the lifeline of Indian Health Sec...
Crafting Bipartisan Policies to Minimize
Crafting Bipartisan Policies to Minimize
by test
Drug Shortages. Nancy E. Dunlap, MD, PhD, MBA. 20...
31-3617ja.
31-3617ja.
by trish-goza
1. Being a Medical Statistician in the Pharmaceut...
The Global Pharmaceutical Industry
The Global Pharmaceutical Industry
by lois-ondreau
Timothy F Christian, MD, MPA. Characteristics of ...
Drug Residue Avoidance in Poultry
Drug Residue Avoidance in Poultry
by yvonne
Poultry Industry. The poultry industry is a dynami...
Drug Products Labeled as HomeopathicGuidance for FDA Staffand Industry
Drug Products Labeled as HomeopathicGuidance for FDA Staffand Industry
by candy
. Submit written comments to the Dockets Managem...
Drug Residue Avoidance in Dairy Cattle
Drug Residue Avoidance in Dairy Cattle
by alida-meadow
Drug Residue Avoidance in Dairy Cattle Dairy Indu...
The Pharmaceutical Industry and The Process of Drug Discovery
The Pharmaceutical Industry and The Process of Drug Discovery
by luanne-stotts
What is a Drug?. Types of Pharmaceutical Products...
Drug Residue Avoidance in Swine
Drug Residue Avoidance in Swine
by myesha-ticknor
Swine Industry. The swine industry . is a vertica...
Bridging the Skills Gap for the Pharmaceutical Industry in South Africa
Bridging the Skills Gap for the Pharmaceutical Industry in South Africa
by test
Human Capital Outlook Implications for Skills Dev...
Drug
Drug
by natalia-silvester
Quality . and . Environmental Requirements. Expec...
( Still?)
( Still?)
by yoshiko-marsland
Changing Times in. Pharmaceutical Statistics. PSI...
Management Review Management
Management Review Management
by natalia-silvester
Representative: First Last. Date: . February . 4....
Recognizing and Avoiding
Recognizing and Avoiding
by natalia-silvester
Financial Conflicts . of . Interest. A Profession...
Translational Research through Public-Private Partnerships
Translational Research through Public-Private Partnerships
by faustina-dinatale
65. th. Annual . Bohan. Lecture. Scott J. Weir...
Pharmaceuticals
Pharmaceuticals
by cheryl-pisano
HSPM 714 J50. Fall 2013. What is the real product...
A First for the Industry
A First for the Industry
by alexa-scheidler
ISPE . Drug Shortages Prevention Plan . Introduct...
Guidance for Industry Residual Drug in Transdermal and Related Drug Delivery Systems U
Guidance for Industry Residual Drug in Transdermal and Related Drug Delivery Systems U
by trish-goza
S Department of Health and Human Services Food and...
Guidance for Industry Interim Product Reporting for Human Drug Compounding Outsourcing Facilities nder Section B of the Federal Food Drug and Cosmetic Act DRAFT GUIDANCE This guidance document is bei
Guidance for Industry Interim Product Reporting for Human Drug Compounding Outsourcing Facilities nder Section B of the Federal Food Drug and Cosmetic Act DRAFT GUIDANCE This guidance document is bei
by giovanna-bartolotta
omments and suggestions regarding this draft docu...
Guidance for Industry Naming of Drug Products Containing Salt Drug Substances DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
Guidance for Industry Naming of Drug Products Containing Salt Drug Substances DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
by karlyn-bohler
Comments and suggestions regarding this draft doc...
Drug Delivery and Generic Medicine
Drug Delivery and Generic Medicine
by conchita-marotz
The Challenge ahead; Choose where to play.. MENA ...
A First for the Industry
A First for the Industry
by karlyn-bohler
ISPE . Drug Shortages Prevention Plan . Introduct...
On ICH Feb. 13, 2013 Toshi
On ICH Feb. 13, 2013 Toshi
by faustina-dinatale
. Tominaga. Ph. D.. Food and Drug Evaluation Ce...
Financial Conflict of Interest and Medical Research
Financial Conflict of Interest and Medical Research
by natalia-silvester
Stephen R. Marder, M.D.. Disclosure Information f...
BIG Pharma….the savings
BIG Pharma….the savings
by calandra-battersby
you can’t see. 1. NAEN CONFERENCE – March 201...
Financial Conflict of Interest and Medical Research
Financial Conflict of Interest and Medical Research
by lois-ondreau
Stephen R. Marder, M.D.. Disclosure Information f...
BIG Pharma….the savings
BIG Pharma….the savings
by tawny-fly
you can’t see. 1. NAEN CONFERENCE – March 201...
2016 Top Markets Report
2016 Top Markets Report
by alis
PharmaceuticalsA Market Assessment Tool for US Exp...
THE ROLE OF PHARMACEUTICALS IN PUBLIC HEALTH ACCESS TO ESSENTIAL MEDI
THE ROLE OF PHARMACEUTICALS IN PUBLIC HEALTH ACCESS TO ESSENTIAL MEDI
by udeline
School of Public HealthTHE ROLE OF PHARMACEUTICALS...
Research and
Research and
by rosemary
At a Glance31is report examines research and devel...
Also a No AG agreement for one drug prohibited No AG agreements p
Also a No AG agreement for one drug prohibited No AG agreements p
by ethlyn
Figure 2-1: Number of Authorized Generic Drugs Lau...
The Biopharmaceutical Industry’s Challenge in Drug Pricing
The Biopharmaceutical Industry’s Challenge in Drug Pricing
by aaron
John L. LaMattina. CURE / Yale . Biohaven. April ...
Guidance for Industry Chronic Fatigue Syndrome Myalgic Encephalomyelitis Developing Drug Products for Treatment DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
Guidance for Industry Chronic Fatigue Syndrome Myalgic Encephalomyelitis Developing Drug Products for Treatment DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
by pamella-moone
Federal Register Federal Register US Department o...
Benefit Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications k with Different Technological Characteristics Draft Guidance for Industry and Food and Drug Admin
Benefit Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications k with Different Technological Characteristics Draft Guidance for Industry and Food and Drug Admin
by tatiana-dople
Document issued on July 15 2014 You should submit...
Guidance for Industry Size of Beads in Drug Products Labeled for Sprinkle U
Guidance for Industry Size of Beads in Drug Products Labeled for Sprinkle U
by myesha-ticknor
S Department of Health and Human Services Food and...
Guidance for Industry Fulfilling Regulatory Requirements for Postmarketing Submission s of Interactive Promotional Media for Prescription Human and Animal Drug and Biologics DRAFT GUIDANCE This guida
Guidance for Industry Fulfilling Regulatory Requirements for Postmarketing Submission s of Interactive Promotional Media for Prescription Human and Animal Drug and Biologics DRAFT GUIDANCE This guida
by tatyana-admore
Comments and suggestions regarding this draft doc...